Condition
Apophysitis
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05174182Not ApplicableCompleted
A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter
NCT01826071Not ApplicableCompleted
Comparison of Three Treatments for Lower Extremity Apophysitis
NCT05220969Completed
Total Genotype Score, Growth, Maturation and Loading Exposure as Risk Factors for Injury in Elite Male Youth Football
NCT03589001Completed
24 Month Follow-up of Patients With Osgood Schlatter (OSD)
Showing all 4 trials